I wonder what if anything us, the shareholders, can do legally to stop this blatant manipulation of our share price. Also, theoretically can we as shareholders file a class action against the FDA for the losses incurred as a result of their hit letter?
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.